---
title: "Research"
---

## Overview

We leverage **human genetics** to identify causal mechanisms of cardiovascular disease, then combine **molecular biology**, **single-cell multi-omics**, and **mouse models** to define how risk variants act in vascular cells—especially **coronary artery smooth muscle**.

---

## Research pillars

::: {.columns .v-center}
::: {.column width="30%"}
![](images/research/pillar-adar1.jpg){width=100% fig-align="center"}
:::
::: {.column width="70%"}
### 1) ADAR1 RNA editing and dsRNA sensing in vascular disease
We study smooth muscle–specific **ADAR1-mediated RNA editing**, dsRNA accumulation, and activation of **MDA5 (IFIH1)** in atherosclerosis and vascular calcification.
:::
:::

::: {.columns .v-center}
::: {.column width="30%"}
![](images/research/pillar-vascularbeds.jpg){width=100% fig-align="center"}
:::
::: {.column width="70%"}
### 2) Vascular-bed specificity at single-cell resolution
We define how **developmental origin** and **vascular bed** shape cell states, enhancers, and genetic risk mechanisms across human vascular disease.
:::
:::

::: {.columns .v-center}
::: {.column width="30%"}
![](images/research/pillar-crispri.jpg){width=100% fig-align="center"}
:::
::: {.column width="70%"}
### 3) Functional genomics for mapping transcriptional network of dsRNA sensing and innate immune activation
We use **CRISPRi screening** with **targeted Perturb-seq (TAP-seq)** to map transcriptional networks of interferon stimulated gene (ISG) activation and dsRNA sensing in human coronary artery smooth muscle cells.
:::
:::

::: {.columns .v-center}
::: {.column width="30%"}
![](images/research/pillar-mouse.jpg){width=100% fig-align="center"}
:::
::: {.column width="70%"}
### 4) Mouse genetics of smooth muscle transition and calcification
We dissect epigenetic and molecular mechanisms using conditional smooth muscle deletion models (e.g., **Pdgfd**, **Sox9**) to connect genetics to disease phenotypes.
:::
:::


---

## Featured publications

::: {.columns}
::: {.column width="33%"}
[![](images/NatCVR_Cover.jpg){fig-align="center" width=90%}](https://doi.org/10.1038/s44161-025-00710-5)
:::

::: {.column width="67%"}
### Smooth muscle cell ADAR1 controls activation of RNA sensor MDA5 in atherosclerosis
**Weldy CS**, et al. *Nature Cardiovascular Research* (2025).  
PMID: 40958051 · DOI: 10.1038/s44161-025-00710-5

- **Cover**: October 2025 issue Nature Cardiovascular Research
- Finalist, **Louis N. and Arnold M. Katz Basic Science Research Prize** (AHA; Nov 16, 2024)
- Highlighted by Stanford Department of Medicine News:  
  <https://medicine.stanford.edu/news/current-news/standard-news/RNA-editing.html>
:::
:::

::: {.columns}
::: {.column width="33%"}
[![](images/MolecularSysBio_Cover.jpg){fig-align="center" width=90%}](https://doi.org/10.1038/s44320-025-00140-2)
:::

::: {.column width="67%"}
### Epigenomic landscape of single vascular cells reflects developmental origin and disease risk loci
**Weldy CS**, et al. *Molecular Systems Biology* (2025).  
PMID: 40931195 · DOI: 10.1038/s44320-025-00140-2

- **Cover**: November 2025 issue Molecular Systems Biology
•	Work highlighted by the Stanford Cardiovascular Institute <https://med.stanford.edu/cvi/mission/news_center/articles_announcements/2025/developmental-memory.html>

:::
:::

---

## Funding

- **NIH/NHLBI K08 (1K08HL167699-01)** — *Aug 2023–Jul 2028* — PI: Chad Weldy  
  “ADAR-mediated RNA editing is a causal mechanism in coronary artery disease” (~$850,000)

- **AHA Career Development Award (23CDA1042900)** — *Jul 2023–Jun 2026* — PI: Chad Weldy  
  “Linking RNA editing to coronary artery calcification and disease” (~$231,000)

- **NIH/NHLBI Loan Repayment Program (LRP)** — Renewal (Jul 2023) — PI: Chad Weldy  
  “RNA editing is a causal mechanism of coronary artery disease”

- **NIH/NHLBI F32 (1F32HL160067-01)** — *Jul 2021–Jun 2023* (completed) — PI: Chad Weldy  
  “A transcriptional network governing smooth muscle transition is mediated by causal CAD gene PDGFD”  
  *Impact score 10 (1st percentile)*

- **NIH/NHLBI Loan Repayment Program (LRP)** — (Jul 2021) — PI: Chad Weldy  
  “Single-cell transcriptomic and epigenomic features of human atherosclerosis”

## In the news

::: {.columns}
::: {.column width="25%"}
[![](images/news/RNAedit.jpg){width=100% style="border-radius:8px;"}](news/2024-11-16-stanford-medicine-rna-editing.html)
:::
::: {.column width="75%"}
### Stanford Medicine highlights our RNA editing work
A Stanford Medicine feature on ADAR1 RNA editing, dsRNA sensing, and implications for cardiovascular disease mechanisms.  
[Read the story →](news/2024-11-16-stanford-medicine-rna-editing.html)
:::
:::

::: {.columns}
::: {.column width="25%"}
[![](images/news/Covers.jpeg){width=100% style="border-radius:8px;"}](news/2025-12-15-developmental-memory-arteries.html)
:::
::: {.column width="75%"}
### Stanford CVI story on developmental “memory” in arteries
How developmental origin leaves a lasting imprint shaping regional vascular disease risk.  
[Read the story →](news/2025-12-15-developmental-memory-arteries.html)
:::
:::
